Device-Related Thrombus After Left Atrial Appendage Occlusion: Clinical Impact, Predictors, Classification, and Management
Despite the unprecedented advances in the left atrial appendage occlusion field, device-
related thrombus (DRT) remains an unresolved issue with the therapy. This paper aims to …
related thrombus (DRT) remains an unresolved issue with the therapy. This paper aims to …
Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis
Q Zhou, X Liu, X Yang, XH Huang, YZ Wu, YY Tao… - Thrombosis …, 2024 - Elsevier
Introduction Left atrial appendage occlusion (LAAO) provides an alternative for poor
candidates of long-term oral anticoagulant (OAC) therapy; however, anticoagulant therapy …
candidates of long-term oral anticoagulant (OAC) therapy; however, anticoagulant therapy …
Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score–matched comparison with direct oral …
Background Long-term oral anticoagulation is the mainstay therapy for thromboembolic (TE)
prevention in patients with atrial fibrillation. However, left atrial appendage occlusion (LAAO) …
prevention in patients with atrial fibrillation. However, left atrial appendage occlusion (LAAO) …
Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion
H Ge, C Zhang, ZQ Qiao, ZY Hao, Z Li… - Science …, 2022 - journals.sagepub.com
Background: Percutaneous left atrial appendage occlusion (LAAO) provides an alternative
for poor candidates for long-term oral anticoagulation (OAC). To prevent device-related …
for poor candidates for long-term oral anticoagulation (OAC). To prevent device-related …
Massive device-related thrombus after LAA occlusion: intraoperative insights into mechanism
D Vukomanovic, S Unzek, K Malik, A Taase… - Case Reports, 2022 - jacc.org
In patients with a contraindication to oral anticoagulation, the left atrial appendage occlusion
devices are an approved alternative. Device-related thrombus is a recognized complication …
devices are an approved alternative. Device-related thrombus is a recognized complication …
Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis
Q Zhou, X Liu, ZC Gu, X Yang, X Huang, Y Wu… - Journal of Thrombosis …, 2024 - Springer
This meta-analysis compared the efficacy and safety of different antithrombotic regimens
after left atrial appendage closure (LAAC). PubMed, Embase, Medline, Cochrane Library …
after left atrial appendage closure (LAAC). PubMed, Embase, Medline, Cochrane Library …
Percutaneous extraction of a large device-related thrombus on a Watchman™ device: a case report
R Vyas, C Kohler, A Pershad - European Heart Journal-Case …, 2022 - academic.oup.com
Background Left atrial appendage occlusion devices are commonly used to prevent stroke
in patients with persistent atrial fibrillation who are unable to tolerate anticoagulation …
in patients with persistent atrial fibrillation who are unable to tolerate anticoagulation …
Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials
C Thomopoulos, J Ntalakouras, D Polyzos… - Pharmacological …, 2022 - Elsevier
Background In standard dosing, direct Oral Anticoagulants (DOACs) are used as an
alternative to warfarin to prevent ischemic stroke and systemic embolism in non-valvular …
alternative to warfarin to prevent ischemic stroke and systemic embolism in non-valvular …
Clopidogrel Resistance in Ischemic Stroke Patients
S Lavanya, D Babu, D Dheepthi… - Annals of Indian …, 2024 - journals.lww.com
Stroke remained the second leading cause of death globally in 2019. The antiplatelet drug
clopidogrel is used to keep blood clots from forming in people who have experienced a …
clopidogrel is used to keep blood clots from forming in people who have experienced a …
La chiusura dell'auricola sinistra: un'alternativa agli anticoagulanti cumarinici nella calcifilassi?
M Andolfatto, M Tangredi, M Vischi, C Pinerolo… - GIORNALE ITALIANO …, 2022 - air.unimi.it
L'arteriolopatia uremico calcifica (CUA), nota anche come calcifilassi, è una patologia rara
potenzialmente fatale che si verifica nel 1-4% della popolazione con insufficienza renale …
potenzialmente fatale che si verifica nel 1-4% della popolazione con insufficienza renale …